More information for you
The indication
What can be treated with
CyberKnife® ?
The treatment of liver diseases, especially primary hepatocellular carcinoma and liver metastases, requires advanced and precise therapy options. The CyberKnife® center in Soest offers an innovative solution for patients suffering from liver diseases. In this article you will learn more about the advantages of CyberKnife® technology in the treatment of liver diseases and why Zentrum Soest plays a leading role in this area.
Brain diseases
A large number of benign and malignant brain tumors can be treated with the CyberKnife® technology.
Lung diseases
Small and well-defined lung tumors can be treated non-invasively with single-stage radiosurgery
Spinal diseases
Benign and malignant spinal tumors represent a suitable indication for CyberKnife® treatment.
Lymph node disease
In certain locations, individual lymph node metastases can be treated with the CyberKnife® technology.
Liver disease
Liver metastases and hepatocellular carcinomas have been successfully treated with the CyberKnife® method for years.
Pancreatic disease
The CyberKnife® method is a low-risk and gentle treatment alternative for pancreatic tumors.
Renal disease
As an alternative to surgery, renal cell carcinomas can be successfully removed using CyberKnife® treatment.
Prostae disease
As an alternative to surgery or conventional radiation, certain prostate carcinomas can be treated well with the Cyberknife method.
Bone metastasis
In advanced stages of the disease, CyberKnife® treatment is a safe option for pain relief in bone metastases.
Contact us
or reach us by phone.
+49 (0) 2921 66687 20
Contact
DEUTSCHES CYBERKNIFE ZENTRUM
Deutsches Zentrum für Stereotaxie
und Präzisionsbestrahlung GmbH
Senator-Schwartz-Ring 8
59494 Soest
Phone : +49 (0) 2921 66687 20
Fax: +49 (0) 2921 66687 22
Mail general: info@dzsp.de
Mail patient request: cyberknife@dzsp.de
© 2023 Deutsches CyberKnife Zentrum